Imatinib Not Yet Recruiting Phase 4 Trials for Chronyc Myeloid Leukemia Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02602314Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia